TY  - JOUR
T1  - A randomized double-blind study of the effect of botox and dysport/reloxin on forehead wrinkles and electromyographic activity
AU  - Karsai S, Adrian R, Hammes S, Thimm J, Raulin C
Y1  - 2007/11/01
N1  - 10.1001/archderm.143.11.1447-b
JO  - Archives of Dermatology
SP  - 1447
EP  - 1462
VL  - 143
IS  - 11
N2  - 
The difference between the potency units of the 2 main botulinum toxin A products, Botox (Allergan, Irvine, California) and Dysport/Reloxin (Ipsen Ltd, Slough, England), is still a subject of discussion even after 15 years of clinical use. The manufacturer of Botox recommends higher ratios than does the manufacturer of Dysport/Reloxin. Herein, we report the findings of a randomized, double-blind, split-face study of forehead wrinkles and electromyographic (EMG) activity following application of the 2 products at a 3:1 dose ratio, independent of the support of either manufacturer.

SN  - 0003-987X
M3  - doi: 10.1001/archderm.143.11.1447-b
UR  - http://dx.doi.org/10.1001/archderm.143.11.1447-b
ER  -